Epidermal disease Advocacy Hub | UniteRare

At a Glance

Live from database

Regulatory Watchboard

10 events

Oct 2026Testing the Safety of the Combination of Anti-Cancer Drugs CX-5461 (Pidnarulex) and Trastuzumab Deruxtecan (T-DXd) for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Solid Tumors and Breast Cancer

National Cancer Institute (NCI) — PHASE1

TrialRECRUITING

Apr 2026Imlunestrant and Abemaciclib for the Treatment of Estrogen Receptor Positive Breast Cancer in Patients With Minimal Residual Disease, MIRI Trial

Jonsson Comprehensive Cancer Center — PHASE2

TrialNOT YET RECRUITING

Apr 2026A Clinical Trial on the Outcomes of Comprehensive Enhanced Prophylaxis Management (CEPM) in Chinese Patients With EGFR-Mutated Advanced NSCLC Receiving Amivantamab-Based Regimens

Shanghai Pulmonary Hospital, Shanghai, China — PHASE4

TrialNOT YET RECRUITING

Apr 2026A Pilot Study on the Efficacy of 2% Cholesterol Cream in Preventing Transepidermal Water Loss and Clinical Symptoms in Mild to Moderate Atopic Dermatitis

Institute of Dermatology, Thailand — NA

TrialENROLLING BY INVITATION

Apr 2026A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC

EpiBiologics — PHASE1

TrialRECRUITING

Mar 2026TILs Plus Third-Generation EGFR-TKI Therapy for TKI-Resistant NSCLC

Tianjin Medical University General Hospital — EARLY_PHASE1

TrialNOT YET RECRUITING

Mar 2026A Study to Investigate Ubamatamab With and Without REGN7075 in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

Regeneron Pharmaceuticals — PHASE2

TrialRECRUITING

Mar 2026Efficacy and Safety of Tinengotinib Tablets Combined With Fulvestrant Injection in Patients With HR Positive and HER-2 Negative Recurrent or Metastatic Breast Cancer Who Have Failed Prior Treatment

TransThera Sciences (Nanjing), Inc. — PHASE2

TrialRECRUITING

Mar 2026The Value of Adding Mini-oral Pulse Steroid Therapy in Preventing Peri-lesional Halo Post Non-cultured Epidermal Cell Suspension (NCES) in Cases With Stable Segmental and Non-acral Vitiligo.

Cairo University — PHASE4

TrialNOT YET RECRUITING

Mar 2026The Value of Methotrexate in NCES for Stable Vitiligo

Cairo University — PHASE4

TrialRECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

Total programs

No financial assistance programs currently listed for Epidermal disease.
Check the disease page for updates →

Clinical Trial Landscape

No active clinical trials currently recruiting for Epidermal disease.
Search all trials →

Search clinical trials for Epidermal disease →

Recent News & Research

No recent news articles indexed yet for Epidermal disease.
Search PubMed for Epidermal disease →

Browse all Epidermal disease news →

Specialist Network

Top 6 by expertise

Global Clinical Leader

Daiichi Sankyo

Score 3644 trials4 pubs

Arun Rajan, M.D., M.D

National Cancer Institute (NCI)

📍 BETHESDA, MD

Score 3111 trials

Project Leader

Ono Pharmaceutical Co. Ltd

Score 2011 trials

BioNTech Responsible Person

BioNTech SE

Score 1318 trials

Jonathan W Goldman

UCLA / Jonsson Comprehensive Cancer Center

Score 82 trials

Si-Yu Wang, MD

Sun Yat-sen University

Score 83 trials

View all Epidermal disease specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰